Global Autologous Matrix-Induced Chondrogenesis (AMIC) Strategic Industry Report 2024: Market to Reach $278 Million by 2030 - Growing Demand for Minimally-Invasive Surgeries to Propel Market Growth - ResearchAndMarkets.com
The "Autologous Matrix-Induced Chondrogenesis (AMIC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
- The "Autologous Matrix-Induced Chondrogenesis (AMIC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
- The global market for Autologous Matrix-Induced Chondrogenesis (AMIC) estimated at US$153 Million in the year 2022, is projected to reach a revised size of US$278 Million by 2030, growing at a CAGR of 7.7% over the analysis period 2022-2030.
- Collagen, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$158.8 Million by the end of the analysis period.
- The Autologous Matrix-Induced Chondrogenesis (AMIC) market is poised for growth due to the increasing prevalence of joint disorders.